A glance into botulinum toxin outpatient clinic in movement disorders practice: self experience

Basit Öğe Kaydı
dc.contributor.authorDeğirmenci, Yıldız
dc.date.accessioned2020-04-30T13:32:04Z
dc.date.available2020-04-30T13:32:04Z
dc.date.issued2019
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractAim: Aim of this study is to determine socio-demographic and disease features of patients who underwent Botulinum toxin injections, and to present our clinical experience via documenting intervals of Botulinum toxin injections and effect-side effect profiles. Material and Methods: Socio-demographic features of patients and characteristic features of Botulinum toxin treatment were recorded. The diagnosis of the patients who underwent Botulinum toxin injections, disease durations and the onset of Botulinum toxin treatments were investigated. Possible side-effects were recorded. Results: Thirty-two patients (20 men, 12 women) with the diagnosis of various types of movement disorders were enrolled the study. Mean age of patients was 60.65±14.40 years (range= 22-83 years). Diagnosis of the patients who underwent Botulinum toxin injections were cervical dystonia, blepharospasm, clonic hemifacial spasm, focal hand dystonia/writer’s cramp, oromandibular dystonia, and dystonic tremor. All patients had repetitive Botulinum toxin injections. There were no remarkable adverse effects, other than mild temporary bruises in injection site in two patients with blepharospasm. Conclusion: Botulinum toxin is an important treatment option in patients with focal dystonia. Botulinum toxin as a neurotoxin of Clostridium botulinum bacteria, suppresses muscle contractions via inhibiting acetylcholine release to the synaptic gap. This reversible effect lasts three to four months due to the neuronal sprouting. It is important to share clinical experiences, data of Botulinum toxin outpatient clinics or clinics from the movement disorders perspective to increase awareness of Botulinum toxin effectivity in patients with movement disorders, focal dystonia particularly. © 2019, Duzce University Medical School. All rights reserved.en_US
dc.identifier.doi10.18678/dtfd.559329en_US
dc.identifier.endpage165en_US
dc.identifier.issn1307671X
dc.identifier.issue3en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage162en_US
dc.identifier.urihttps://dx.doi.org/10.18678/dtfd.559329
dc.identifier.urihttps://hdl.handle.net/20.500.12684/32
dc.identifier.volume21en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherDuzce University Medical Schoolen_US
dc.relation.ispartofDüzce Tıp Fakültesi Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBotulinum toxin; Focal distonia; Movement disordersen_US
dc.titleA glance into botulinum toxin outpatient clinic in movement disorders practice: self experienceen_US
dc.title.alternativeHareket bozuklukları pratiğinde botulinum toksin polikliniğine bakış: Kişisel deneyimen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
0032.pdf
Boyut:
336.85 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Düzce Tıp Fakültesi Dergisi Koleksiyonu
Makale Koleksiyonu